Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-24

Clinical Trial Update: A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial update for PCRX-201 assessing safety and tolerability in osteoarthritis of the knee; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PCRX-201

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis (OA) of the Knee | Phase 2 | Status: ACTIVE_NOT_RECRUITING